Triflora NDC 53499-7290

NDC codes

FDA NDC Directory

Product NDC (as listed)53499-7290Labeler and product segments. Claims need a package NDC.

Product NDC at billing width53499-7290Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
53499-7290-8	53499729008	1 TUBE in 1 CARTON (53499-7290-8) / 77 g in 1 TUBEMarketed from Oct 1, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Triflora
Generic name (nonproprietary): urtica doicia, rhus toxicodendron, ledum palustre
Active ingredients: Urtica dioica — 1 [hp_X]/77gToxicodendron pubescens leaf — 4 [hp_X]/77gLedum palustre twig — 2 [hp_X]/77g
Dosage form: Gel
Route: Topical
Labeler: Schwabe North America, Inc
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Oct 1, 2021
Listing expires: Dec 31, 2026
Identifiers: Product ID 53499-7290_be615942-cb86-4d3d-8177-efc815ac4ff8SPL ID be615942-cb86-4d3d-8177-efc815ac4ff8SPL set ID 0f7796ae-a20e-431f-bdec-bca7415b468fUNII 710FLW4U46, 6IO182RP7A, 877L01IZ0PUPC 0308078252971

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N453499729008 followed by a unit qualifier and the quantity

Package 53499-7290-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 18, 2025.

Indications (excerpt from the label)

Indications & Usage Temporarily relieves minor aches, pains, and joint/muscle stiffness associated with arthritis, rheumatism, simple backache, and tendinitis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)